MedPath

SULINDAC

SULINDAC TABLETS USP

Approved
Approval ID

f4985b1b-7e2c-4911-897a-94c337794bab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 10, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sulindac

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-2093
Application NumberANDA072051
Product Classification
M
Marketing Category
C73584
G
Generic Name
sulindac
Product Specifications
Route of AdministrationORAL
Effective DateApril 26, 2021
FDA Product Classification

INGREDIENTS (4)

SULINDACActive
Quantity: 200 mg in 1 1
Code: 184SNS8VUH
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
starch, cornInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SULINDAC - FDA Drug Approval Details